Strides Pharma hits 52-week high as CDMO arm secures ₹801 cr in pre-listing round

October 16, 2024
Uncategorized

Strides Pharma Science announced that its associate, OneSource Specialty Pharma, has raised ₹801 crore from domestic and foreign institutional investors in a pre-listing round.

Strides Pharma hits 52-week high as CDMO arm secures ₹801 cr in pre-listing round

Leave a ReplyCancel Reply

CG Power Q3 Results: Stock falls 4% after earnings miss, dividend declared

Hindalco Industries to invest ₹21,000 crore in Odisha smelter expansion

Markets recover from volatility, Sensex rises 320 points, Nifty closes above 25,150

European stocks are ‘finally’ improving, UBS says, as it lists where it sees the most upside

Tata Consumer Products Q3 Results: India business leads margin expansion, Foods aids growth